BRIEF published on 03/26/2026 at 22:24, 5 months 29 days ago DBV Technologies publie ses rapports financiers pour 2025 AMF Rapport Financier SEC DBV Technologies VIASKIN®
BRIEF published on 03/26/2026 at 22:24, 5 months 29 days ago DBV Technologies Files 2025 Annual Report and Registration Document Financial Filing Annual Report Universal Registration Document Form 10-K DBV Technologies
BRIEF published on 03/26/2026 at 22:24, 5 months 29 days ago DBV Technologies dépose son rapport annuel 2025 et son document d'enregistrement Document D'Enregistrement Universel Rapport Annuel Déclaration Financière Formulaire 10-K Technologies DBV
BRIEF published on 03/26/2026 at 22:24, 5 months 29 days ago DBV Technologies publishes its financial reports for 2025 AMF Financial Report DBV Technologies DRY VIASKIN®
PRESS RELEASE published on 03/26/2026 at 22:19, 5 months 29 days ago DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document DBV Technologies files 2025 Annual Report on Form 10-K and Universal Registration Document with SEC and AMF. Company developing treatments for food allergies Annual Report Immunotherapy Form 10-K DBV Technologies Food Allergies
PRESS RELEASE published on 03/26/2026 at 22:19, 5 months 29 days ago DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2025 DBV Technologies publie son Form 10-K américain et son Document d’Enregistrement Universel 2025 pour l’exercice 2025. Informations financières et gouvernance disponibles en ligne Biopharmaceutique Form 10-K DBV Technologies Allergies Alimentaires Document D’Enregistrement Universel 2025
BRIEF published on 03/24/2026 at 21:35, 6 months ago DBV Technologies rejoint les indices CAC Mid 60 et SBF 120 Euronext Paris SBF 120 DBV Technologies CAC Mid 60 Inclusion Indices
BRIEF published on 03/24/2026 at 21:35, 6 months ago DBV Technologies joins the CAC Mid 60 and SBF 120 indices Euronext Paris SBF 120 DBV Technologies CAC Mid 60 Inclusion Indices
BRIEF published on 03/24/2026 at 21:35, 6 months ago DBV Technologies intègre les indices CAC Mid 60 et SBF 120 Biopharmaceutique SBF 120 CAC Mid 60 VIASKIN® Technologies DBV
BRIEF published on 03/24/2026 at 21:35, 6 months ago DBV Technologies Joins CAC Mid 60 and SBF 120 Indices Biopharmaceutical SBF 120 DBV Technologies CAC Mid 60 VIASKIN®
Published on 09/25/2026 at 17:30, 3 hours 2 minutes ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 5 hours 32 minutes ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/25/2026 at 14:00, 6 hours 32 minutes ago Karbon-X (OTCQB:KARX) to Present Global Growth Strategy and Showcase SkyXero at 26th MK-Equity Investment Conference in Munich
Published on 09/25/2026 at 13:00, 7 hours 32 minutes ago Core Silver Announces Grant of Stock Options
Published on 09/25/2026 at 13:00, 7 hours 32 minutes ago American Hotel Income Properties REIT LP Announces Corporate Update
Published on 09/25/2026 at 18:30, 2 hours 2 minutes ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:00, 2 hours 32 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:30, 3 hours 2 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/25/2026 (French only)
Published on 09/25/2026 at 17:30, 3 hours 2 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 25/09/2026
Published on 09/25/2026 at 17:45, 2 hours 47 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 hours 52 minutes ago Availability of the 2026 half-year financial report
Published on 09/25/2026 at 17:40, 2 hours 52 minutes ago Mise à disposition du rapport financier semestriel 2026
